Diabetic Kidney Disease: Routes to drug development, pharmacology and underlying molecular mechanisms, Volume II

7,495
Total downloads
21k
Total views and downloads

Articles

SYSTEMATIC REVIEW

Published on 27 Mar 2025

Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials

Jingyi Guo
Maoying Wei
Wenhua Zhang
Yijia Jiang
Aijing Li
Churan Wang
Dan Yin
Anning Sun
Yanbing Gong

doi 10.3389/fphar.2025.1517272

231 views

ORIGINAL RESEARCH

Accepted on 03 Mar 2025

Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: A multi-omics study

Li Jiang
Hongda Yu
Jie Jian
Xulin Sai
Xiai Wu

doi 10.3389/fphar.2025.1506896

SYSTEMATIC REVIEW

Accepted on 28 Feb 2025

Renal protective effects of vitamin E for drug-induced kidney injury: A systematic review and meta-analysis

Lingfei Meng
Shengmao Liu
Xinmiao Shi
Wenpeng Cui

doi 10.3389/fphar.2025.1461792

SYSTEMATIC REVIEW

Published on 27 Jan 2025

Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis

Yahui Yuan
Chun Chen
Yuping Lin
Yehao Luo
Zhaojun Yang
Jingyi Guo
Qiaoyun Liu
Lu Sun
Guanjie Fan

doi 10.3389/fphar.2024.1462965

584 views

REVIEW

Published on 22 Jan 2025

Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis

Xiaoming Li
Rui Xu
Dan Zhang
Ji Cai
He Zhou
Tao Song
Xianyao Wang
Qinghong Kong
Liujin Li
4 more
Jidong Zhang

doi 10.3389/fphar.2025.1511083

1,040 views

ORIGINAL RESEARCH

Published on 21 Jan 2025

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

Yan Ye
Xiaopeng Huang
Xueying Li
Fei Gao
Wenzhen Zhong
Anqi Tang
Liangbin Zhao
Dengpiao Xie
Naijing Ye

doi 10.3389/fphar.2024.1453668

752 views

ORIGINAL RESEARCH

Published on 03 Jan 2025

FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle

Yudie Zhang
Fan Wang
Chongyang Zhang
Fan Yao
Bin Zhang
Yongping Zhang
Xiaobo Sun

doi 10.3389/fphar.2024.1500458

615 views

ORIGINAL RESEARCH

Published on 15 Nov 2024

β-cryptoxanthin suppresses oxidative stress via activation of the Nrf2/HO-1 signaling pathway in diabetic kidney disease

Jingjing Ke
Hualong Zang
Yang Liu
Qiuping Teng
Jiao Hua
Dan Peng
Ping Wang

doi 10.3389/fphar.2024.1480629

713 views

ORIGINAL RESEARCH

Published on 28 Oct 2024

Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis

Hongmei Yu
Haitao Tang
Rengui Saxu
Yuhui Song
Xu Cui
Jingjing Xu
Nan Li
Siyuan Cui
Haitao Ge
1 more
Harvest F. Gu

doi 10.3389/fphar.2024.1424968

1,037 views

ORIGINAL RESEARCH

Published on 22 Oct 2024

Sphagnum cuspidatulum extract prevents acute kidney injury induced by high-fat diet and streptozotocin via alleviation of oxidative stress and apoptosis in pre-diabetic rats

Pongrapee Laorodphun
Sutheera Chaisen
Sarocha Amattat
Pornchita Maphet
Narin Printrakul
Hataichanok Pandith
Aussara Panya
Burit Kongmali
Myat Theingi Swe
Phatchawan Arjinajarn

doi 10.3389/fphar.2024.1464463

726 views

REVIEW

Published on 04 Oct 2024

Exploring potential targets for natural product therapy of DN: the role of SUMOylation

Jingjing Wang
Rui Zhang
Chenguang Wu
Lifan Wang
Peng Liu
Ping Li

doi 10.3389/fphar.2024.1432724

1,257 views

ORIGINAL RESEARCH

Published on 29 Aug 2024

Assessment of the effect of the SLC5A2 gene on eGFR: a Mendelian randomization study of drug targets for the nephroprotective effect of sodium-glucose cotransporter protein 2 inhibition

Gailing Liu

doi 10.3389/fendo.2024.1418575

1,054 views

Share on

Frontiers in Pharmacology

Renal Pharmacology

Impact

21kTopic views
13kArticle views
7,495Article downloads

View impact

Articles

Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials

Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: A multi-omics study

Renal protective effects of vitamin E for drug-induced kidney injury: A systematic review and meta-analysis

Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis

Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle

β-cryptoxanthin suppresses oxidative stress via activation of the Nrf2/HO-1 signaling pathway in diabetic kidney disease

Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis

Sphagnum cuspidatulum extract prevents acute kidney injury induced by high-fat diet and streptozotocin via alleviation of oxidative stress and apoptosis in pre-diabetic rats

Exploring potential targets for natural product therapy of DN: the role of SUMOylation

Assessment of the effect of the SLC5A2 gene on eGFR: a Mendelian randomization study of drug targets for the nephroprotective effect of sodium-glucose cotransporter protein 2 inhibition

Frontiers in Pharmacology

Renal Pharmacology